Bé 3 ơi à....
#16
(2020-12-01, 10:38 AM)Mimo Wrote:  

Vậy là Bé 3 đi học ...trường Đời trên núi Trần Gian....

Mà mùa này cũng nên hạn chế đi lang thang bé ơi, bởi vì đi đâu cũng phải ghé vô ...public restroom và restaurant...chổ đó tàn là monster Covid không đoá...
Chừng nào có vaccin thì mới travel tiếp...
Take care, lâu lâu ghé vô họp lớp VB nhé Heavy-black-heart4 Hug Tulip4


 Thank you, sis Mimo Hello

Bé 3 muốn học nhiều thứ lắm, ai dạy là mình học ah... Tulip4

Từ hồi Covid hoành hành tới giờ, bé 3 cũng ít ra ngoài public, hình như đi biển có một lần sau khi họ mở cửa.. Biggrin


Bên bé 3 có chỗ này offer Covid 19 vaccine nè,  có ai muốn thử không?

OHSU looking for Portland-area residents to take part in research trial for COVID-19 vaccine

The national clinical trial hopes to enroll 40,000 participants nationwide, who will receive two injections four weeks apart and will be monitored for two years.
[Image: 6547c8c1-fa3c-4d1e-aaeb-dfb88c67f9e8_1920x1080.jpg]looking for Portland-area residents to take part in research trial f
PORTLAND, Ore. — Oregon Health & Science University is looking for adults who live in the Portland area to take part in a research study into the safety and effectiveness of a potential COVID-19 vaccine.
OHSU is involved in a Phase 3 clinical trial to evaluate the vaccine candidate developed by Oxford University and pharmaceutical company AstraZeneca known as ASD1222.

[size=undefined]
OHSU is the only Oregon institution involved in the third phase of this clinical trial.
The national clinical trial is looking to enroll 40,000 participants nationwide, according to OHSU. Those selected will receive two injections four weeks apart and will be monitored for two years.
The university is looking for a diverse group of people to participate in the trial and will "prioritize the enrollment of individuals who are older than 55 and Black, Indigenous and People of Color," OHSU said in a press release.
To reach communities hit hardest by the pandemic, Dr. Marcel Curlin, OHSU's lead investigator on the study and associate professor of infectious disease in the School of Medicine, has been meeting with different groups to describe the trial and encourage participation.
"It's very important to have all these groups represented and not be left behind as we go forward with research," Curlin told KGW. "So, when something comes out we know it works in all those groups and it's accessible to those groups. You need both of those things."
Here are the other eligibility requirements for the study:[/size]
  • 18 or older
  • Not pregnant
  • Stable medical condition or no medical issues
  • Not previously diagnosed with COVID-19
  • Live within 1.5 hours of the OHSU Marquam Hill/South Waterfront campus in Portland

Reply